共 50 条
- [43] Ulcerative Colitis Therapy: Vedolizumab as a First-line Biologic Agent? ZEITSCHRIFT FUR GASTROENTEROLOGIE, 2022, 60 (03): : 274 - 276
- [44] Is rituximab suitable for use as a first-line biologic therapy for RA? NATURE CLINICAL PRACTICE RHEUMATOLOGY, 2008, 4 (11): : 574 - 575
- [45] Is rituximab suitable for use as a first-line biologic therapy for RA? Nature Clinical Practice Rheumatology, 2008, 4 : 574 - 575
- [47] First-line biologic therapy with tumor necrosis factor inhibitors for psoriatic arthritis: a prospective observational study SAO PAULO MEDICAL JOURNAL, 2022, 140 (06): : 787 - 797
- [48] Infections in Patients With Rheumatoid Arthritis Undergoing Anti-TNF alpha Drug Therapy REUMATOLOGIA CLINICA, 2008, 4 : 18 - 23